Consortium of Neuroimmunology of Mood Disorders and Alzheimer's Disease. (360G-Wellcome-104025_Z_14_Z)
We propose to form a consortium of academic and industrial partners to address the therapeutic challenges of Alzheimers disease and mood disorders by a shared, innovative focus on immunological mechanisms of these key neuropsychiatric disorders and their treatment by anti-inflammatory drugs. The industrial partners (Janssen and Lundbeck) will contribute drug discovery know-how and access to anti-inflammatory drugs. The academic partners will contribute expertise in neuroimaging, clinical phen otyping, animal models and informatics. The work will be organised as two programmes, focused on Alzheimer's disease and mood disorders, and four cross-cutting technical platforms (cytometry, proteomics, PET and MRI). In phase 1 (years 1-3), we will validate peripheral immunological phenotypes, e.g., cytokine levels or macrophage transcriptomes, as markers of Alzheimer's disease and mood disorders. We will seek mechanistically to link peripheral immunophenotypes to markers of central (brain) inflammation and microglial activation; to brain function and behaviour; and to longitudinal changes in the clinical phenotypes and animal models. In phase 2 (years 3-5), we will use these biomarkers in experimental medicine studies designed to test mechanism-of-action and / or therapeutic proof-of-concept of anti-inflammatory drugs in immunologically stratified cohorts of patients with Alzheimer's disease or mood disorders.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 3434869 |
Applicant Surname | Bullmore |
Approval Committee | Strategic Awards Committee |
Award Date | 2014-04-10T00:00:00+00:00 |
Financial Year | 2013/14 |
Grant Programme: Title | Strategic Award - Science |
Internal ID | 104025/Z/14/Z |
Lead Applicant | Prof Edward Bullmore |
Other Applicant(s) | Dr Declan Jones, Dr Thomas Moeller, Prof Carmine Pariante, Prof Federico Turkheimer, Prof Jonathan Cavanagh, Prof Paul Morgan, Prof Peter St George-Hyslop, Prof Sir Simon Lovestone, Prof Victor Perry, Prof Wayne Drevets |
Partnership Value | 3434869 |
Planned Dates: End Date | 2023-06-30T00:00:00+00:00 |
Planned Dates: Start Date | 2015-01-18T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |